Global DTP Vaccines Market Size and Forecast 2024-2033| GlaxoSmithKline, Sanofi, Merck & Co Inc., Meiji Holdings Co., Ltd., Shenzhen Kangtai Biological Products

DTP (Diphtheria-Tetanus-Pertussis) vaccine for injection

The DTP Vaccines by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The DTP Vaccines Market:

https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report

According to The Business Research Company’s DTP Vaccines, The dtp vaccines market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.56 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increase in healthcare access, continuous protection towards infectious diseases and rising awareness of immunization.

The dtp vaccines market size is expected to see strong growth in the next few years. It will grow to $8.63 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to strong late-stage pipeline and new drug approvals, increased healthcare expenditure and immunization policies to eradicate endemic diseases. Major trends in the forecast period include focusing on development of combination vaccines, investing extensively in r&d activities, using artificial intelligence (ai) in vaccine development and focusing on strategic acquisitions.

Governments all over the world are encouraging the development of DTP vaccines in order to prevent the spread of the disease. Countries such as India have the Universal Immunization Programme that aims to provide recommended vaccines against tuberculosis, polio, and other diseases including diphtheria, tetanus, and whooping cough for all Indian children. The country regularly conducts vaccination drives, which are expected to positively impact the growth of the market. These initiatives are expected to drive the growth of the market in the forecast period.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=3453&type=smp

The dtp vaccines market covered in this report is segmented –

1) By Product type: DTaP, TD, Tdap

2) By Disease: Diphtheria, Pertussis, Tetanus

3) By End-User: Hospitals, Clinics, Vaccination Centers

Major companies operating in the diphtheria, tetanus, and pertussis (DTP) vaccine market are focusing on developing innovative vaccines such as BOOSTRIX to gain a competitive edge in the market. BOOSTRIX is a vaccine used to help protect adolescents (ages 10–18) and adults against certain diseases caused by bacteria called Bordetella pertussis, diphtheria, and tetanus. It’s a combination vaccine that helps prevent whooping cough (pertussis), diphtheria, and tetanus. For instance, in October 2022, GSK plc, a UK-based biotechnology and pharmaceutical company, launched BOOSTRIX, which received approval from the US Food and Drug Administration (FDA). This is the first vaccine that has been specifically licensed for use by pregnant women to protect unborn children from illness. It enhances the mother’s antibodies, which are passed on to the growing baby when given during pregnancy.

The dtp vaccines market report table of contents includes:

1. Executive Summar

2. DTP Vaccines Market Characteristics

3. DTP Vaccines Market Trends And Strategies

4. DTP Vaccines Market – Macro Economic Scenario

5. Global DTP Vaccines Market Size and Growth

26. South America DTP Vaccines Market

27. Brazil DTP Vaccines Market

28. Middle East DTP Vaccines Market

29. Africa DTP Vaccines Market

30. DTP Vaccines Market Competitive Landscape And Company Profiles

Top Major Players: